The University of Notre Dame Australia’s Institute for Health Research (IHR) and MGC Pharma have announced publication of the study protocol for a clinical trial evaluating medical cannabis use with patients with dementia. The trial was registered in the Australian and New Zealand Clinical Trial Register (ANZCTR) earlier this week. The research project, which we … Continue reading Medical Cannabis Dementia Trial Study Protocol Published